Fuchs Endothelial Corneal Dystrophy Fecd clinical trials

Explore recruiting fuchs endothelial corneal dystrophy fecd clinical trials.

Also recruiting in Europe

Fuchs Endothelial Corneal Dystrophy Fecd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared with Vehicle in Subjects with Fuchs Endothelial Corneal Dystrophy (FECD) - PHANTOM Study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects with Fuchs Endothelial Corneal Dystrophy

Denmark, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Fuchs Endothelial Corneal Dystrophy Fecd trials by city

Fuchs Endothelial Corneal Dystrophy Fecd in Toronto Fuchs Endothelial Corneal Dystrophy Fecd in Vancouver Fuchs Endothelial Corneal Dystrophy Fecd in Montreal Fuchs Endothelial Corneal Dystrophy Fecd in Calgary Fuchs Endothelial Corneal Dystrophy Fecd in Edmonton Fuchs Endothelial Corneal Dystrophy Fecd in Ottawa Fuchs Endothelial Corneal Dystrophy Fecd in Winnipeg Fuchs Endothelial Corneal Dystrophy Fecd in Quebec City Fuchs Endothelial Corneal Dystrophy Fecd in Hamilton Fuchs Endothelial Corneal Dystrophy Fecd in Kitchener Fuchs Endothelial Corneal Dystrophy Fecd in London Fuchs Endothelial Corneal Dystrophy Fecd in Halifax Fuchs Endothelial Corneal Dystrophy Fecd in New York Fuchs Endothelial Corneal Dystrophy Fecd in Los Angeles Fuchs Endothelial Corneal Dystrophy Fecd in Chicago Fuchs Endothelial Corneal Dystrophy Fecd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease